Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 51216-51217 [2016-18372]

Download as PDF 51216 Federal Register / Vol. 81, No. 149 / Wednesday, August 3, 2016 / Notices • Mail comments to: David Cullison, Office of the Chief Information Officer, Mail Stop: T–5 F53, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001. For additional direction on obtaining information and submitting comments, see ‘‘Obtaining Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. FOR FURTHER INFORMATION CONTACT: David Cullison, Office of the Chief Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415– 2084; email: INFOCOLLECTS.Resource@ NRC.GOV. SUPPLEMENTARY INFORMATION: asabaliauskas on DSK3SPTVN1PROD with NOTICES I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2016– 0070 when contacting the NRC about the availability of information for this action. You may obtain publiclyavailable information related to this action by any of the following methods: • Federal rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2016–0070. A copy of the collection of information ‘‘NRC Form 212, Qualifications Investigation, Professional, Technical and Administrative Positions’’ and related instructions may be obtained without charge by accessing Docket ID NRC– 2016–0070 on this Web site. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. A copy of the collection of information and related instructions may be obtained without charge by accessing ADAMS Accession ML16168A149. The supporting statement is available in ADAMS under Accession No. ML16168A215. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. • NRC’s Clearance Officer: A copy of the collection of information and related instructions may be obtained without VerDate Sep<11>2014 18:21 Aug 02, 2016 Jkt 238001 charge by contacting NRC’s Clearance Officer, David Cullison, Office of the Chief Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415– 2084; email: INFOCOLLECTS.Resource@ NRC.GOV. B. Submitting Comments Please include Docket ID NRC–2016– 0070 in the subject line of your comment submission, in order to ensure that the NRC is able to make your comment submission available to the public in this docket. The NRC cautions you not to include identifying or contact information in comment submissions that you do not want to be publicly disclosed in your comment submission. The NRC will post all comment submissions at https:// www.regulations.gov as well as enter the comment submissions into ADAMS, and the NRC does not routinely edit comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the NRC, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment into ADAMS. II. Background In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35), the NRC is requesting public comment on its intention to request the OMB’s approval for the information collection summarized below. 1. The title of the information collection: ‘‘NRC Form 212, Qualifications Investigation, Professional, Technical and Administrative Positions.’’ 2. OMB approval number: 3150–0033. 3. Type of submission: Extension. 4. The form number: NRC Form 212. 5. How often the collection is required or requested: On occasion. The forms are collected for every new hire to the NRC. 6. Who will be required or asked to respond: Former employers, supervisors, and other references indicated on job applications are asked to complete the NRC Form 212. 7. The estimated number of annual responses: 1,000. 8. The estimated number of annual respondents: 0. PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 9. The estimated number of hours needed annually to comply with the information collection requirement or request: 500 hours. 10. Abstract: Information requested on NRC Form 212, ‘‘Qualifications Investigation, Professional, Technical, and Administrative Positions’’ is used to determine the qualifications and suitability of external applicants for employment with the NRC. The completed form may be used to examine, rate and/or assess the prospective employee’s qualifications. The information regarding the qualifications of applicants for employment is reviewed by professional personnel of the Office of the Chief Human Capital Officer, in conjunction with other information in the NRC files, to determine the qualifications of the applicant for appointment to the position under consideration. III. Specific Requests for Comments The NRC is seeking comments that address the following questions: 1. Is the proposed collection of information necessary for the NRC to properly perform its functions? Does the information have practical utility? 2. Is the estimate of the burden of the information collection accurate? 3. Is there a way to enhance the quality, utility, and clarity of the information to be collected? 4. How can the burden of the information collection on respondents be minimized, including the use of automated collection techniques or other forms of information technology? Dated at Rockville, Maryland, this 28th day of July 2016. For the Nuclear Regulatory Commission. David Cullison, NRC Clearance Officer, Office of the Chief Information Officer. [FR Doc. 2016–18304 Filed 8–2–16; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: NRC will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on October 6–7, 2016. A sample of agenda items to be discussed during the public session includes: An update on medicalrelated events; a discussion on the reporting of medical events for various SUMMARY: E:\FR\FM\03AUN1.SGM 03AUN1 Federal Register / Vol. 81, No. 149 / Wednesday, August 3, 2016 / Notices modalities; a discussion on the licensing guidance for yttrium-90 microsphere brachytherapy; a discussion on the training and experience requirements for authorized individuals for various modalities; a presentation from Spectrum Pharmaceuticals, Inc. on the training and experience requirements for alpha and beta emitters; an update on the worldwide supply of molybdenum-99; and a discussion on the licensing guidance for the NorthStar® Generator. The agenda is subject to change. The current agenda and any updates will be available at https://www.nrc.gov/reading-rm/doccollections/acmui/meetings/2016.html or by emailing Ms. Michelle Smethers at the contact information below. Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material. Date and Time for Open Sessions: October 06, 2016, from 8:00 a.m. to 3:00 p.m. and October 07, 2016, from 8:00 a.m. to 4:00 p.m. Data and Time for Closed Sessions: October 06, 2016, from 7:00 a.m. to 8:00 a.m. and from 3:00 p.m. to 5:00 p.m. Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T2– B3, 11545 Rockville Pike, Rockville, Maryland 20852. Public Participation: Any member of the public who wishes to participate in the meeting in person or via phone should contact Ms. Smethers using the information below. The meeting will also be webcast live: video.nrc.gov. FOR FURTHER INFORMATION CONTACT: Michelle Smethers, email: michelle.smethers@nrc.gov, telephone: (301) 415–6711. asabaliauskas on DSK3SPTVN1PROD with NOTICES Conduct of the Meeting Philip O. Alderson, M.D., will chair the meeting. Dr. Alderson will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Smethers using the contact information listed above. All submittals must be received by October 3, 2016, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s Web site https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ VerDate Sep<11>2014 18:21 Aug 02, 2016 Jkt 238001 2016.html on or about November 22, 2016. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Smethers of their planned attendance. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10 of the Code of Federal Regulations, part 7. Dated at Rockville, Maryland, this 28th day of July, 2016. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. 2016–18372 Filed 8–2–16; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2016–0045] Steam Generator Materials and Design Nuclear Regulatory Commission. ACTION: Standard review plan—final section revision; issuance. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is issuing a final revision to Section 5.4.2.1, ‘‘Steam Generator Materials and Design,’’ of NUREG–0800, ‘‘Standard Review Plan [SRP] for the Review of Safety Analysis Reports for Nuclear Power Plants: LWR [Light Water Reactor] Edition.’’ Revision 4 to Section 5.4.2.1 of the SRP reflects current NRC review methods and practices based on lessons learned from NRC reviews of design certification and combined license applications completed since the last revision of this section. DATES: The effective date of Revision 4 to Section 5.4.2.1 of the SRP is September 2, 2016. ADDRESSES: Please refer to Docket ID NRC–2016–0045 when contacting the NRC about the availability of information regarding this document. You may obtain publicly-available information related to this document using any of the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2016–0045. Address questions about NRC dockets to Carol Gallagher; telephone: 301–415–3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individuals listed in the FOR FURTHER INFORMATION CONTACT section of this document. SUMMARY: PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 51217 • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. A markup showing the Revision 4 changes made to SRP Section 5.4.2.1, and the final revision of SRP Section 5.4.2.1, Revision 4, are available in ADAMS under Accession Nos. ML16147A298 and ML16147A289. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. • The NUREG–0800 is available on the NRC’s public Web site at https:// www.nrc.gov/reading-rm/doccollections/nuregs/staff/sr0800/. FOR FURTHER INFORMATION CONTACT: Carolyn Lauron, telephone: 301–415– 2736, email: Carolyn.Lauron@nrc.gov; or Mark Notich, telephone: 301–415.3053, email: Mark.Notich@nrc.gov. Both are staff of the Office of New Reactors, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001. SUPPLEMENTARY INFORMATION: I. Background On April 22, 2016 (81 FR 23762), the NRC published for public comment the proposed revisions to SRP Section 5.4.2.1. The NRC received no comments on the proposed revisions. Therefore, the NRC is issuing Revision 4 to Section 5.4.2.1 of the SRP in final form for use. There have been minor editorial changes to this section since its issuance in proposed form for public comment. Details of the specific changes are included at the end of the revised section, under the subsection titled, ‘‘Description of Changes.’’ Revision 4 to Section 5.4.2.1 of the SRP reflects current NRC review methods and practices based on lessons learned from NRC reviews of design certification and combined license applications completed since the last revision of this section. II. Backfitting and Finality Provisions Issuance of this revised SRP section does not constitute backfitting as defined in § 50.109 of title 10 of the Code of Federal Regulations (10 CFR), ‘‘Backfitting,’’ (the Backfit Rule) or E:\FR\FM\03AUN1.SGM 03AUN1

Agencies

NUCLEAR REGULATORY COMMISSION

[Federal Register Volume 81, Number 149 (Wednesday, August 3, 2016)]
[Notices]
[Pages 51216-51217]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-18372]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: NRC will convene a meeting of the Advisory Committee on the 
Medical Uses of Isotopes (ACMUI) on October 6-7, 2016. A sample of 
agenda items to be discussed during the public session includes: An 
update on medical-related events; a discussion on the reporting of 
medical events for various

[[Page 51217]]

modalities; a discussion on the licensing guidance for yttrium-90 
microsphere brachytherapy; a discussion on the training and experience 
requirements for authorized individuals for various modalities; a 
presentation from Spectrum Pharmaceuticals, Inc. on the training and 
experience requirements for alpha and beta emitters; an update on the 
worldwide supply of molybdenum-99; and a discussion on the licensing 
guidance for the NorthStar[supreg] Generator. The agenda is subject to 
change. The current agenda and any updates will be available at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2016.html or by 
emailing Ms. Michelle Smethers at the contact information below.
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.
    Date and Time for Open Sessions: October 06, 2016, from 8:00 a.m. 
to 3:00 p.m. and October 07, 2016, from 8:00 a.m. to 4:00 p.m.
    Data and Time for Closed Sessions: October 06, 2016, from 7:00 a.m. 
to 8:00 a.m. and from 3:00 p.m. to 5:00 p.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-B3, 11545 Rockville Pike, 
Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Smethers using the information below. The meeting will also be webcast 
live: video.nrc.gov.

FOR FURTHER INFORMATION CONTACT: Michelle Smethers, email: 
michelle.smethers@nrc.gov, telephone: (301) 415-6711.

Conduct of the Meeting

    Philip O. Alderson, M.D., will chair the meeting. Dr. Alderson will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Smethers using the contact information listed 
above. All submittals must be received by October 3, 2016, and must 
pertain to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's Web site https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2016.html on or about November 22, 2016.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Smethers of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10 of the Code of Federal Regulations, part 7.

    Dated at Rockville, Maryland, this 28th day of July, 2016.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2016-18372 Filed 8-2-16; 8:45 am]
 BILLING CODE 7590-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.